SureTrader
Home > Boards > US OTC > Medical - Equipment >

Titan Medical Inc. (TITXF)

TITXF RSS Feed
Add TITXF Price Alert      Hide Sticky   Hide Intro
Moderator: glg20, drrc1949, investinthefuture, cptjsd, Longmoney, SPORT19
Search This Board: 
Last Post: 2/23/2018 11:36:23 AM - Followers: 337 - Board type: Free - Posts Today: 7



Titan Medical SPORT Surgical System
Surgeon Feedback From Initial Clinical Testing:

Ricardo Estape, M.D., a robotic gynecologic oncology surgeon from South Miami Gynecology Oncology Group who specializes in robotic single port surgeries, said, “The SPORT Surgical System performed beyond my expectations and I was able to complete a variety of critical surgical tasks with the necessary dexterity and precision through a single incision. The robotic instruments provided the necessary articulation, range of motion and rigidity along with 3D high-definition video on the flat panel monitor that allowed me to complete the surgery in a comfortable posture. This could be a game changer in gynecological surgery.”  SEE VIDEO

Eduardo Parra-Davila, M.D., a robotic colorectal surgeon at Florida Hospital who has trained thousands of surgeons worldwide on robotic surgery, commented, “Single port surgery without robotic assistance is not easy and yet it remains highly beneficial because of the desire to have fewer ports. It’s all about robotic articulation delivered through a single incision that allows for the reach, necessary angles and multi-quadrant access to treat diseases in colorectal surgeries. The SPORT Surgical System has the promise to become a valuable tool for all robotic surgeons looking to do single port surgery in the future.”    SEE VIDEO

Arnold Advincula, M.D., Chief of Gynecologic Specialty Surgery at Columbia University and an expert in robotic surgery, said, “After using the SPORT system, I am more convinced that single-port robotic surgery could become a reality for many patients. Previous approaches to single-incision surgery have been limiting and ineffective. The SPORT system demonstrated that it can not only address those limitations, but it may also provide some unique capabilities for enabling a variety of gynecologic surgeries through a single incision. The future of single-port robotic surgery is bright and I am excited to actively participate in this journey with Titan Medical.”

Vipul Patel, M.D., a world-renowned robotic urology surgeon from the Global Robotics Institute at Florida Hospital and the only surgeon in the world to have completed 10,000 robotic prostatectomies, said, “Although multi-port robotic prostatectomy is currently the standard of care in urology, single port robotic surgery could be the next frontier in urology and other surgical disciplines. It was exciting for me to use Titan Medical’s SPORT system at Florida Hospital Nicholson Center. The technological capabilities of the SPORT system are very encouraging and the early success in establishing feasibility is an important step in the right direction.”

William Burke, M.D., a gynecologic oncologist at Stony Brook University Hospital with extensive robotic surgery experience, commented, “Having completed thousands of multi-port robotic surgeries over several years of practice, I was pleased with the capabilities of the SPORT system that eased my transition from a multi-port approach to single-port robotic surgery. The workspace, access and ease of use while maintaining critical multi-port robotic features such as multi-articulated instruments and high-definition 3D visualization through a single incision, are important factors in transitioning from multi-port to single-port robotic surgery. I must say that the SPORT system, with its sophistication, makes a highly compelling case for single-port robotic surgery.”

Lee Swanstrom, MD, FACS, Chief Innovation Officer of IHU Strasbourg, said, “I was pleased with my first experience with the SPORT system for applications in abdominal procedures. There are many patients undergoing general surgical procedures who could greatly benefit from a reduced number of incisions. Single-port robotic surgery can be a truly enabling solution for patients and surgeons alike, and it is exciting to see that the SPORT system takes us much closer to that possibility.”

Jelle Ruurda, MD, a gastrointestinal and oncologic surgeon at University Medical Center Utrecht, who has several years of robotic surgery experience, commented, “Many oncologic general surgery procedures require specimen retrieval at the end of the procedure. These procedures are natural applications for single-port robotic surgery. My first operation of the SPORT system in a preclinical environment was very exciting, and the system shows great promise for future clinical use. I look forward to the opportunity to work together with Titan Medical to evolve a single-port robotic surgery option for my oncology patients. Based on this first experience, I am confident that single-port robotic surgery has a bright future”.

Eric Barret, MD, a world-renowned robotic urologic surgeon at Institut Mutualiste Montsouris, said, “Having performed many single-incision robotic surgeries with flexible, non-wristed and crossed-over instruments, my first experience with the SPORT system was exceptional. The SPORT system addresses many limitations of previous laparoscopic and robotic single-incision surgery approaches, and holds significant promise for meaningful use in urologic applications.”


                                                                                                             SPORT™ Surgical System

A robotic system like no other!

The SPORT Surgical System is a versatile single incision advanced robotic surgical system that features state-of the-art multi-articulated instruments with single-use replaceable tips, 3D high definition visualization on a flat-screen monitor, ergonomic open workstation and a single-arm mobile patient cart for ease of set up while enabling broad applications of single and multi-quadrant surgeries previously not possible with current robotic solutions.

Titan Medical Inc. is a Canadian public company, headquartered in Toronto, Ontario, that trades on the Toronto Stock Exchange (TMD) and the OTCQX in the United States (TITXF). Titan is developing the SPORT™ (Single Port Orifice Robotic Technology) Surgical System for use in minimally invasive surgery (“MIS”) that is expected to be commercially available in 2019. Titan’s robotic surgical system is being designed to expand robotic surgery into areas that are currently underserviced. This will allow surgeons to perform procedures within small to medium size surgical spaces such as general surgery and cholecystectomy. Currently, the most common medical procedures for which robotic systems are used are hysterectomies and prostatectomies. Titan plans to expand the scope and obtain approval for various surgical procedures as outlined in their Corporate Presentation.   http://www.titanmedicalinc.com/


The SPORT™ Surgical System includes the following:
                        
* a single-port surgeon controlled robotic platform that includes a 3D vision system and interactive instruments for performing MIS procedures, and

* a surgeon workstation that provides the surgeon with an interface to the robotic platform   for controlling the interactive instruments and providing a 3D endoscopic view of inside a patient’s body during MIS procedures.

 

David J. McNally, Chief Executive Officer, Director

 

Mr. McNally joins Titan after serving as the founder, President, CEO and Chairman of the Board of Domain Surgical Inc., founded in 2009, Domain is based in Salt Lake City, Utah. Mr. McNally brings substantial experience in areas of extraordinary leadership skills with all facets of building innovative medical device companies including clinically-focused product design and development, capital formation, regulatory clearance, and commercialization. Mr. McNally earned an MBA from the University of Utah, holds a Bachelor of Science degree in Mechanical Engineering from Lafayette College, Easton, PA and is the co-inventor of more than 30 U.S. and international patents associated with ferromagnetic surgical devices and systems, electromagnetic and ultrasonic sensors, and medical fluid delivery systems





 

                                                                                  Surgeon Advisory Board

Arnold Advincula, MD

Dr. Advincula is Vice-Chair of Women’s Health & Chief of Gynecology at the Sloane Hospital for Women, Columbia University Medical Center/New York Presbyterian Hospital. Formerly, he was Professor of Obstetrics and Gynecology, Director of the Minimally Invasive Surgery Division and Fellowship, and Director of the Endometriosis Center at the University of Michigan. More recently, he was Director of the Center for Specialized Gynecology and Director of the Education Institute at the Nicholson Center, an advanced medical and surgical simulation training facility at Florida Health. He is currently Vice President of the American Association of Gynecologic Laparoscopy and a Member-at-Large for the Society of Gynecologic Surgeons. He is a leader in minimally invasive surgical techniques and one of the world’s most experienced gynecologic robotic surgeons, who has published and taught extensively in the area of minimally invasive surgery, as well as developed surgical instruments that are in use worldwide.

Juliane Bingener-Casey, MD

Dr. Juliane Bingener is Professor of Surgery, Mayo Clinic College of Medicine, and Vice Chair for Quality, Safety and Service in the Mayo Clinic Department of Surgery. She has a joint appointment in the Division of Gastroenterology and Hepatology, which supports her clinical interests in minimally invasive surgery, endoscopy, and gastrointestinal disease. Her research focuses on patient reported outcomes and novel technology in the diagnosis and treatment of these diseases. Dr. Bingener’s previous work included the development of a Natural Orifice Translumenal Endoscopic Surgery (NOTES) technique for using an omental patch to close perforated ulcers. Her ongoing interests focus on the development, study, and implementation of innovative endoscopic and laparoscopic approaches for gastrointestinal diseases.

W. Douglas Boyd, MD

Dr. Boyd is a Professor of Surgery and Director of Robotics and Biosurgery at the University of California Davis. He is Head of Adult Cardiac Surgery and Surgical Director of the Transcatheter Valve Program. He is recognized for his pioneering work in cardiothoracic surgery and for his use of robotic-assisted surgical systems. He specializes in minimally invasive cardiac and robotic-assisted heart surgery. Dr. Boyd completed the world’s first closed-chest, beating-heart coronary artery bypass surgery using a robotic system in 1999. Prior to his appointment as a professor of surgery at UC Davis Health System, Dr. Boyd served as chair of the Department of Cardiothoracic Surgery at the Cleveland Clinic in Florida. As the author of more than 70 peer-reviewed, journal articles, Dr. Boyd’s research interests include cardiac tissue regeneration using extracellular matrix/stem cells, new techniques for robot-assisted minimally invasive coronary artery revascularization, valve surgery and tele-surgery. He is a graduate of Carleton University in Ottawa, Canada and obtained his medical degree from the University of Ottawa, Canada.

Demetrius EM Litwin, MD, MBA, FRCS, FACS, FICS

Dr. Litwin trained in General Surgery at the University of Saskatchewan, and completed a hepatobiliary fellowship at the University of Toronto. He was an early pioneer in laparoscopic surgery, having performed the first laparoscopic cholecystectomy in Western Canada in 1990 and the first laparoscopic colectomy in Canada in 1991. He was a leader in educating a large number of surgeons across Canada in basic and advanced laparoscopic techniques. During the early advent of minimally invasive surgery, he innovated new laparoscopic approaches to the spine and aorta, and he participated in the development of HandPortTM, a hand assist device for laparoscopic surgery. In 1993, Dr. Litwin became the Director of Minimally Invasive Surgery at the University of Toronto. In 1997, he moved to the University of Massachusetts as Chief of Minimally Invasive Surgery. Since 2004, he has been Chairman of Surgery at the University of Massachusetts Medical School and UMass Memorial Medical Center, one of the largest Academic Health Sciences Centers in Massachusetts. There, he continues to practice minimally invasive surgery of the abdomen in addition to his administrative role.

Lee L Swanstrom, MD, FACS

Dr. Swanstrom heads the Division of GI and Minimally Invasive Surgery at the Oregon Clinic and is Director of the Providence Health System’s Complex GI and Foregut Surgery Postgraduate Fellowship Program. In addition, he is Clinical Professor in the Department of Surgery at OHSU, a Director of the American Board of Surgery, and Past President of both the Society of American Gastrointestinal Endoscopic Surgeons (SAGES) and the Fellowship Council (FC). Most recently, he became the Chief Innovations Officer and Director of the Innovations Fellowship at the Institutes des Hôpitalo Universitaires of the University of Strasbourg, France. He is the editor of Surgical Innovation and the author of over 300 scientific papers and 50 book chapters. This has resulted in 13 patents and a successful medical device startup company. He is and has been an investigator on numerous outcomes research studies for new procedures such as Natural Orifice Translumenal Endoscopic Surgery (NOTES) to determine their safety and efficacy for establishing new standards of care. He remains focused on developing innovative approaches to the minimally invasive treatment of foregut and other gastrointestinal disorders.

John Valvo, MD

Dr. Valvo, a practicing surgeon, is the Executive Director of Robotic and Minimally Invasive Surgery at Rochester General Hospital in Rochester, New York, where he formerly was the Chief of Urology. Following a 20-year career performing open surgery, Dr. Valvo founded the robotic surgery program at Rochester General Hospital in early 2004, which currently ranks in the top two percent of robotic surgery volume in the United States. The program has trained over 30 robotic surgeons and enabled the completion of more than 7,000 robotic urology, gynecology, general and colorectal surgeries to date. Dr. Valvo has authored more than 100 scientific articles and helped start many robotic programs in the northeast. His focus on robotic surgery credentialing led to a notable published paper on policy guidelines for robotic surgery. He is a fellow of the American College of Surgeons and American Urological Association, and a member of the Society for Laparoscopic Surgeons. 

 
 

 

 

 

SECURED PATENTS

  Patent #                                                    Title of Invention
1 8,930,027   Force Feedback System
2 8,792,688   Methods, systems and devices for three dimensional input and control methods and systems based thereon
3 8,768,509   Snaking robotic arm with movable shapers
4 8,347,754   Multi articulating robotic instrument
5 8,332,072   Robotic hand controller
6 8,306,656   Method and system for performing medical procedure
7 8,224,485   Snaking robotic arm with movable shapers
8 5,853,394   Catheter
9 5,607,407   Catheter assembly
10 4,785,868   Medical needle and method for making
  PENDING PATENTS
  PUB. APP. NO.  Title
1 20140316435 METHODS, SYSTEMS AND DEVICES FOR THREE DIMENSIONAL INPUT AND CONTROL METHODS AND SYSTEMS BASED THEREON
2 20140276956 APPARATUS AND METHOD FOR CONTROLLING AN END-EFFECTOR ASSEMBLY
3 20140249546 APPARATUS AND METHOD FOR SUPPORTING A ROBOTIC ARM
4 20140230595 APPARATUS AND METHOD FOR CONTROLLING AN END-EFFECTOR ASSEMBLY
5 20130197697 FORCE FEEDBACK SYSTEM
6 20130197538 ROBOTIC HAND CONTROLLER
7 20120253513 SNAKING ROBOTIC ARM WITH MOVABLE SHAPERS
8 20100036393 METHODS, SYSTEMS AND DEVICES FOR THREEDIMENSIONAL INPUT, AND CONTROL METHODS AND SYSTEMS BASED THEREON

   
SureTrader
TITXF
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
SureTrader
TITXF News: Small Company Offering and Sale of Securities Without Registration (d) 11/02/2017 02:04:07 PM
TITXF News: Small Company Offering and Sale of Securities Without Registration (d) 11/02/2017 02:01:35 PM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#34285  Sticky Note Titan Medical Facebook Group https://www.facebook.com/groups/TitanMedical.info/ SPORT19 03/19/16 10:14:24 AM
#59940   Mustang I have the greatest respect for your posts, NoTshirt 10/05/17 09:29:05 AM
#59938   After what we just saw happen, it doesn’t Bronzo 10/05/17 07:54:03 AM
#59936   I noticed the same glitch. At 4:30, TD scalpel 10/05/17 06:50:52 AM
#59935   So, what happened to "award-winning IP" at Titan? 66Mustang 10/05/17 06:43:42 AM
#59934   Those numbers happen to be (maybe coincidence, maybe 66Mustang 10/05/17 06:39:00 AM
#59929   So your saying don't be a shareholder when SPORT19 10/04/17 07:39:33 PM
#59928   No Lawsuits possible until after sales and production. Backfermore 10/04/17 06:43:11 PM
#59927   What big player? ISRG? More robots are coming. SPORT19 10/04/17 06:14:55 PM
#59926   One request on concern, both of which I NoTshirt 10/04/17 06:10:53 PM
#59925   .228 SPORT19 10/04/17 05:54:45 PM
#59924   So what did we close at? I ORrep8 10/04/17 05:45:34 PM
#59923   Going down. Buy more at 0.12- 0.14. If Jayhawk913 10/04/17 04:45:14 PM
#59922   Goodbye good times. Watching Titan Stock is like Backfermore 10/04/17 04:21:40 PM
#59921   I should rephrase, every day is a great BigT82 10/04/17 11:46:16 AM
#59920   I agree, and I watch like a hawk QuidWilson 10/04/17 11:28:25 AM
#59919   thats actually not healthy. glg20 10/04/17 11:12:18 AM
#59918   It's easy to become neurotic watching the price QuidWilson 10/04/17 11:10:43 AM
#59917   ISRG making new all time highs everyday..... TRXC in SPORT19 10/04/17 11:01:24 AM
#59916   Don't know about it being a great day, Bristol19 10/04/17 10:46:31 AM
#59915   Relax everyone. Titan is killing it! Gonna BigT82 10/04/17 10:01:36 AM
#59914   average joe buys on the news and then glg20 10/04/17 09:18:24 AM
#59913   I'm seeing 2500 shares on the bid and 66Mustang 10/04/17 09:11:00 AM
#59912   On the way up people said it was SPORT19 10/04/17 09:05:43 AM
#59911   just waiting for the press release. glg20 10/04/17 08:51:28 AM
#59910   a raise glg20 10/04/17 08:49:30 AM
#59909   Not good SPORT19 10/04/17 08:49:08 AM
#59908   Level Ii showing a big gap down.... scalpel 10/04/17 08:43:13 AM
#59907   Actually looks like the first test of the EIT 10/03/17 11:58:20 PM
#59906   Same here. Does not have the feel of EIT 10/03/17 11:36:51 PM
#59905   Possible, but why bring Randall?? Flenderson 10/03/17 10:48:45 PM
#59904   If you go to the website and pull Honeycomb777 10/03/17 10:18:03 PM
#59903   Isn’t possible they simply went over to oversee Adrock 10/03/17 09:37:23 PM
#59902   As busy as McNally is I don't think Flenderson 10/03/17 09:11:25 PM
#59901   Like! Backfermore 10/03/17 08:09:32 PM
#59900   Preach it BKT !!! scalpel 10/03/17 07:57:29 PM
#59899   Exactly! Amen brother BigT82 10/03/17 07:41:02 PM
#59898   In the past month we have doubled our bet kids tuition 10/03/17 07:15:26 PM
#59897   SIMPLE MATH suckitup 10/03/17 07:02:39 PM
#59896   It’s a big time negative. We could be ORrep8 10/03/17 06:12:40 PM
#59895   I promised myself I wouldn't check this week QuidWilson 10/03/17 05:52:14 PM
#59894   Agree 100% BigT82 10/03/17 05:27:36 PM
#59893   Rezanating! Adrock 10/03/17 05:13:34 PM
#59892   I've been out grabbing a warrant for JH's Honeycomb777 10/03/17 05:10:25 PM
#59891   Again, I don't believe this is finance related. Flenderson 10/03/17 05:02:26 PM
#59889   post #59862 TheMint 10/03/17 04:37:45 PM
#59888   Same here and I’ll be a buyer if Adrock 10/03/17 04:34:35 PM
#59887   Ok. Yes I know, and I am sorry BigT82 10/03/17 04:33:36 PM
#59886   you could excersice then sell off and double glg20 10/03/17 04:32:14 PM
#59885   Lol. First you say u think it will BigT82 10/03/17 04:32:04 PM
#59884   Silly??? I’ve been here bigt!! I wasn’t sure if Adrock 10/03/17 04:31:56 PM
PostSubject